Preclinical Safety and Pharmacokinetic Profile of 3K3A-APC, a Novel, Modified Activated Protein C for Ischemic Stroke

Publisher: Bentham Science Publishers

E-ISSN: 1873-4286|18|27|4215-4222

ISSN: 1381-6128

Source: Current Pharmaceutical Design, Vol.18, Iss.27, 2012-09, pp. : 4215-4222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content